CD26 expression in mature B-cell neoplasia: its possible role as a new prognostic marker in B-CLL.

scientific article

CD26 expression in mature B-cell neoplasia: its possible role as a new prognostic marker in B-CLL. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1002/HON.888
P8608Fatcat IDrelease_frzokepk5jheziiysne7jsayam
P698PubMed publication ID19247978

P50authorMassimo GentileQ88195209
Fortunato MorabitoQ90396313
Sonia FabrisQ39052038
Luca BaldiniQ39052059
Stefano MolicaQ59660152
P2093author name stringAndrea Ferrario
Francesca Rossi
Antonino Neri
Manlio Ferrarini
Giovanna Cutrona
Marta Lionetti
Lilla Cro
Nadia Zucal
P2860cites workDiagnostic role and prognostic significance of a simplified immunophenotypic classification of mature B cell chronic lymphoid leukemiasQ78800345
Zeta-chain associated protein 70 and CD38 combined predict the time to first treatment in patients with chronic lymphocytic leukemiaQ81324241
Genomic aberrations and survival in chronic lymphocytic leukemiaQ28141442
CD26/dipeptidyl peptidase IV in context. The different roles of a multifunctional ectoenzyme in malignant transformationQ33701851
CD38 expression and immunoglobulin variable region mutations are independent prognostic variables in chronic lymphocytic leukemia, but CD38 expression may vary during the course of the disease.Q33956997
CD26: a multifunctional integral membrane and secreted protein of activated lymphocytes.Q34368489
CD38 expression is an important prognostic marker in chronic lymphocytic leukaemia.Q34521017
Guidelines on the diagnosis and management of chronic lymphocytic leukaemiaQ35746607
Constitutive expression of CD26/dipeptidylpeptidase IV on peripheral blood B lymphocytes of patients with B chronic lymphocytic leukaemia.Q36617545
The CD38 ectoenzyme family: advances in basic science and clinical practiceQ36767533
The cytoplasmic tail of the T cell receptor zeta chain is required for signaling via CD26.Q39255555
Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors.Q39809953
Skin homing of Sézary cells involves SDF-1-CXCR4 signaling and down-regulation of CD26/dipeptidylpeptidase IV.Q40365618
Regulation of p38 phosphorylation and topoisomerase IIalpha expression in the B-cell lymphoma line Jiyoye by CD26/dipeptidyl peptidase IV is associated with enhanced in vitro and in vivo sensitivity to doxorubicinQ40440044
Functional role of CD26 on human B lymphocytesQ41377278
CD26/dipeptidyl peptidase IV expression in human lymphomas is restricted to CD30-positive anaplastic large cell and a subset of T-cell non-Hodgkin's lymphomasQ41413255
Clinical significance of CD38 expression in chronic lymphocytic leukemiaQ43775864
Cell surface peptidase CD26/dipeptidylpeptidase IV regulates CXCL12/stromal cell-derived factor-1 alpha-mediated chemotaxis of human cord blood CD34+ progenitor cellsQ44241973
Constitutive activation of extracellular signal-regulated kinase and p38 mitogen-activated protein kinase in B-cell lymphoproliferative disordersQ44458721
Association of CD26 with CD45RA outside lipid rafts attenuates cord blood T-cell activationQ44606441
World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997.Q46038765
Combined analysis of ZAP-70 and CD38 expression as a predictor of disease progression in B-cell chronic lymphocytic leukemia.Q53864608
ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia.Q55036524
CD38 is a signaling molecule in B-cell chronic lymphocytic leukemia cellsQ57374952
Regulation of CD26/DPPIV gene expression by interferons and retinoic acid in tumor B cellsQ57662605
Fibronectin interaction with α4β1 integrin prevents apoptosis in B cell chronic lymphocytic leukemia: correlation with Bcl-2 and BaxQ58498644
Molecular and transcriptional characterization of 17p loss in B-cell chronic lymphocytic leukemiaQ60197192
Relevance of CD49d protein expression as overall survival and progressive disease prognosticator in chronic lymphocytic leukemiaQ60358460
CD49d in B-cell chronic lymphocytic leukemia: correlated expression with CD38 and prognostic relevanceQ60358511
Clinical significance of ZAP-70 protein expression in B-cell chronic lymphocytic leukemiaQ60358526
CD38 and ZAP-70 are functionally linked and mark CLL cells with high migratory potentialQ61640131
Reversible anergy of sIgM-mediated signaling in the two subsets of CLL defined by VH-gene mutational statusQ62028005
Molecular characterization of dipeptidyl peptidase activity in serumQ62660688
CD26 (dipeptidyl peptidase IV/DPP IV) as a novel molecular marker for differentiated thyroid carcinomaQ71820188
Cross-linking of CD26 by antibody induces tyrosine phosphorylation and activation of mitogen-activated protein kinaseQ73307202
Aberrant dipeptidyl peptidase IV (DPP IV/CD26) expression in human hepatocellular carcinomaQ73677307
P433issue3
P304page(s)140-147
P577publication date2009-09-01
P1433published inHematological OncologyQ15762617
P1476titleCD26 expression in mature B-cell neoplasia: its possible role as a new prognostic marker in B-CLL.
P478volume27

Reverse relations

cites work (P2860)
Q36979261Accelerated progression of chronic lymphocytic leukemia in Eμ-TCL1 mice expressing catalytically inactive RAG1.
Q24628943Automated pattern-guided principal component analysis vs expert-based immunophenotypic classification of B-cell chronic lymphoproliferative disorders: a step forward in the standardization of clinical immunophenotyping
Q39816788CD26 expression on T cell lines increases SDF-1-alpha-mediated invasion
Q57801281CD26 is a potential therapeutic target by humanized monoclonal antibody for the treatment of multiple myeloma
Q42279712CD26: A prognostic marker of other systemic malignancies besides colo-rectal carcinomas
Q38848633CD49d associates with nodal presentation and subsequent development of lymphadenopathy in patients with chronic lymphocytic leukaemia
Q37510305CD9 negatively regulates CD26 expression and inhibits CD26-mediated enhancement of invasive potential of malignant mesothelioma cells
Q38751579Cut to the chase: a review of CD26/dipeptidyl peptidase-4's (DPP4) entanglement in the immune system
Q38760903DPPIV/CD26: a tumor suppressor or a marker of malignancy?
Q35653850Developing Molecular Signatures for Chronic Lymphocytic Leukemia
Q52776417Development and analytical performance of a new ARCHITECT automated dipeptidyl peptidase-4 immunoassay.
Q35723683Differential Expression and Enzymatic Activity of DPPIV/CD26 Affects Migration Ability of Cervical Carcinoma Cells.
Q44713190Dipeptidyl peptidase IV: serum activity and expression on lymphocytes in different hematological malignancies.
Q36124370Improved ZAP-70 assay using two clones, multiple methods of analysis and clinical correlation
Q35113393Potential of soluble CD26 as a serum marker for colorectal cancer detection.
Q40539875Prognostic relevance of stromal CD26 expression in rectal cancer after chemoradiotherapy
Q34386621Serum activity of DPPIV and its expression on lymphocytes in patients with melanoma and in people with vitiligo
Q37948956Surface profiles for subclassification of chronic lymphocytic leukemia.
Q52323624Targeting the Adenosinergic Axis in Chronic Lymphocytic Leukemia: A Way to Disrupt the Tumor Niche?
Q37674999The dipeptidyl peptidase IV family in cancer and cell biology.

Search more.